Outcomes and risk factors of hemorrhage in patients with resected brain metastases
What's New? Brain metastases may present with hemorrhage, yet risk factors and clinical outcomes remain unclear. Based on a cohort of 880 patients with resected brain metastases, this study identified tumor volume and primary tumor histology (melanoma and non‐small cell lung cancer) as key predictors of hemorrhage.
Melisa S. Guelen +17 more
wiley +1 more source
Heparin Provides Antiviral Activity Against Rhinovirus-16 via an Heparan Sulfate Proteoglycan-Independent Mechanism. [PDF]
Helgers LC +5 more
europepmc +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai +4 more
wiley +1 more source
What's New? Venous thromboembolism (VTE) is common in cancer patients, with direct oral anticoagulants, including rivaroxaban, recommended as first‐line therapy. However, oral anticoagulant use is limited due to the growing use of targeted therapy and concerns about drug‐drug interactions.
Esther M. Hollander +7 more
wiley +1 more source
Successful Management of Early High-Risk Pulmonary Embolism Following Elective Coronary Artery Bypass Grafting (CABG) Using Intravenous Unfractionated Heparin Alone. [PDF]
Ballas CE +3 more
europepmc +1 more source
Preparation and in vivo effectiveness evaluation of heparin-loaded PLGA@PCL core-shell fiber small-diameter vascular grafts. [PDF]
Xiao Y +10 more
europepmc +1 more source
Rutin Exhibits In-Vitro Anticoagulant Activity in Human Blood Samples by Prolonging Coagulation Pathway Times. [PDF]
Palikhey A +5 more
europepmc +1 more source
Efficacy and safety of anticoagulant therapy in sepsis: A systematic review and meta-analysis. [PDF]
Lu J, Zhang Z, Wang L.
europepmc +1 more source
Alternative Anticoagulation for Patients with Heparin-Induced Thrombocytopenia on ECMO: A Narrative Review. [PDF]
Unic-Stojanovic D +6 more
europepmc +1 more source
Role of heparin-induced HGF release in the acute phase of STEMI. [PDF]
Leboube S +9 more
europepmc +1 more source

